BIOCAN NOVEL PUPPY, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
BIOCAN NOVEL PUPPY, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Authorised
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Product identification
Medicine name:
BIOCAN NOVEL PUPPY, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Active substance:
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live7.00/log10 50% tissue culture infectious dose1.00Dose
-
Canine distemper virus, strain CDV Bio 11/A, Live5.50/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Additional information
Entitlement type:
-
Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- 2025-03-05 Nr. ĮV-1060
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
- Bertas Nams SIA
Destination wholesaler:
- Vetfarmas UAB
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet